A) Warfarin Tablets BP 0.5mg
B) Warfarin Tablets BP 1mg
C) Warfarin Tablets BP 2mg
D) Warfarin Tablets BP 3mg
E) Warfarin Tablets BP 5mg
GENERIC NAME OF THE MEDICINAL PRODUCT:
QUALITATIVE AND QUANTITATIVE COMPOSITION:
A) Warfarin Tablets BP 0.5mg
Each uncoated tablet contains:
Warfarin Sodium Clathrate BP
Equivalent to
Warfarin (as anhydrous) …………0.5mg
Excipients………………………………q.s.
B) Warfarin Tablets BP 1mg
Each uncoated tablet contains:
Warfarin Sodium Clathrate BP
Equivalent to
Warfarin (as anhydrous) …………1mg
Excipients………………………………q.s.
C) Warfarin Tablets BP 2mg
Each uncoated tablet contains:
Warfarin Sodium Clathrate BP
Equivalent to
Warfarin (as anhydrous) …………2mg
Excipients………………………………q.s.
D) Warfarin Tablets BP 3mg
Each uncoated tablet contains:
Warfarin Sodium Clathrate BP
Equivalent to
Warfarin (as anhydrous) …………3mg
Excipients………………………………q.s.
E) Warfarin Tablets BP 5mg
Each uncoated tablet contains:
Warfarin Sodium Clathrate BP
Equivalent to
Warfarin (as anhydrous) …………5mg
Excipients………………………………q.s.
Each uncoated tablet contains:
Warfarin Sodium Clathrate BP
Equivalent to
Warfarin (as anhydrous) …………0.5mg
Excipients………………………………q.s.
B) Warfarin Tablets BP 1mg
Each uncoated tablet contains:
Warfarin Sodium Clathrate BP
Equivalent to
Warfarin (as anhydrous) …………1mg
Excipients………………………………q.s.
C) Warfarin Tablets BP 2mg
Each uncoated tablet contains:
Warfarin Sodium Clathrate BP
Equivalent to
Warfarin (as anhydrous) …………2mg
Excipients………………………………q.s.
D) Warfarin Tablets BP 3mg
Each uncoated tablet contains:
Warfarin Sodium Clathrate BP
Equivalent to
Warfarin (as anhydrous) …………3mg
Excipients………………………………q.s.
E) Warfarin Tablets BP 5mg
Each uncoated tablet contains:
Warfarin Sodium Clathrate BP
Equivalent to
Warfarin (as anhydrous) …………5mg
Excipients………………………………q.s.
THERAPEUTIC INDICATIONS:
Warfarin is also used to treat or prevent venous thrombosis (swelling and blood clot in a vein) and pulmonary embolism (a blood clot in the lung).
Warfarin is in a class of medications called anticoagulants ('blood thinners'). It works by decreasing the clotting ability of the blood.
There are most common indications for warfarin therapy are; atrial fibrillation (AF), venous thromboembolism (VTE), and prosthetic heart valves. Atrial fibrillation is probably the most common indication for warfarin therapy in our community.
Warfarin is in a class of medications called anticoagulants ('blood thinners'). It works by decreasing the clotting ability of the blood.
There are most common indications for warfarin therapy are; atrial fibrillation (AF), venous thromboembolism (VTE), and prosthetic heart valves. Atrial fibrillation is probably the most common indication for warfarin therapy in our community.
CAUTION & WARNING:
CAUTION: Dispense in a tight, light-resistance container as defined in the USP, with a child-resistance closer.
Swallow whole do not chew or crush.
Not suitable for children under 5 years.
Dispense with medication guide.
For use under medical supervision only.
WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.
Swallow whole do not chew or crush.
Not suitable for children under 5 years.
Dispense with medication guide.
For use under medical supervision only.
WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE & DOSAGE:
Storage: Store at 25°C.
Store in cool, dry & dark place.
Protect from light.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Dosage: As directed by the Physician.
Store in cool, dry & dark place.
Protect from light.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Dosage: As directed by the Physician.
Warfarin Tablets BP 3mg Technical Specification:
| Product Name: | Warfarin Tablets BP 3mg |
| Brand Name: | Generics |
| Strength: | 0.5mg, 1mg, 2mg, 3mg, 5mg |
| Dosage Form: | Uncoated Tablets |
| Route of Administration: | Via oral Route |
| Packing: | 10s, 30s, 100s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
| Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
| Therapeutic use: | Anti-coagulant (Blood thinner) |
| Indication: | Warfarin is also used to treat or prevent venous thrombosis and pulmonary embolism. Warfarin is in a class of medications called anticoagulants (‘blood thinners’). It works by decreasing the clotting ability of the blood |
| Storage: | Store at 25°C. Store in cool, dry & dark place. Protect from light. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Warfarin Tablets BP 3mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Warfarin Tablets BP 3mg
Each uncoated tablet contains:
Warfarin Sodium Clathrate BP
Equivalent to
Warfarin (as anhydrous) …………3mg
Excipients………………………………q.s.
THERAPEUTIC INDICATIONS:
Warfarin is also used to treat or prevent venous thrombosis (swelling and blood clot in a vein) and pulmonary embolism (a blood clot in the lung).
Warfarin is in a class of medications called anticoagulants (‘blood thinners’). It works by decreasing the clotting ability of the blood.
There are most common indications for warfarin therapy are; atrial fibrillation (AF), venous thromboembolism (VTE), and prosthetic heart valves. Atrial fibrillation is probably the most common indication for warfarin therapy in our community.
CAUTION & WARNING:
CAUTION: Dispense in a tight, light-resistance container as defined in the USP, with a child-resistance closer.
Swallow whole do not chew or crush.
Not suitable for children under 5 years.
Dispense with medication guide.
For use under medical supervision only.
Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE & DOSAGE:
Storage: Store at 25°C. Store in cool, dry & dark place. Protect from light.
Keep medicine out of reach of children.
Dosage: As directed by the Physician.
